Found: 56
Select item for more details and to access through your institution.
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1538, doi. 10.3390/cancers16081538
- By:
- Publication type:
- Article
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5240, doi. 10.3390/cancers15215240
- By:
- Publication type:
- Article
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2734, doi. 10.3390/cancers14112734
- By:
- Publication type:
- Article
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13073-019-0669-z
- By:
- Publication type:
- Article
Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer.
- Published in:
- Journal of Oncology, 2012, p. 1, doi. 10.1155/2012/541353
- By:
- Publication type:
- Article
Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARα.
- Published in:
- FASEB Journal, 2006, v. 20, n. 12, p. 2142, doi. 10.1096/fj.06-5900fje
- By:
- Publication type:
- Article
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer.
- Published in:
- BMC Genomics, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12864-019-5457-z
- By:
- Publication type:
- Article
Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries.
- Published in:
- BJUI Compass, 2021, v. 2, n. 4, p. 267, doi. 10.1002/bco2.70
- By:
- Publication type:
- Article
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2417274, doi. 10.1001/jamanetworkopen.2024.17274
- By:
- Publication type:
- Article
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Phase II Clinical Trial Results.
- Published in:
- AUANews, 2023, p. 4
- By:
- Publication type:
- Article
Does Perioperative Testosterone Predict Post-Prostatectomy Genomic Risk Score?
- Published in:
- AUANews, 2022, v. 27, p. 41
- By:
- Publication type:
- Article
Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Commentary.
- Published in:
- Prostate, 2023, v. 83, n. 6, p. 614, doi. 10.1002/pros.24486
- By:
- Publication type:
- Article
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
- Published in:
- Prostate, 2022, v. 82, p. S73, doi. 10.1002/pros.24373
- By:
- Publication type:
- Article
Identifying and treating ROBO1<sup>−ve</sup>/DOCK1<sup>+ve</sup> prostate cancer: An aggressive cancer subtype prevalent in African American patients.
- Published in:
- Prostate, 2020, v. 80, n. 13, p. 1045, doi. 10.1002/pros.24018
- By:
- Publication type:
- Article
A four‐gene transcript score to predict metastatic‐lethal progression in men treated for localized prostate cancer: Development and validation studies.
- Published in:
- Prostate, 2019, v. 79, n. 14, p. 1589, doi. 10.1002/pros.23882
- By:
- Publication type:
- Article
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
- Published in:
- Prostate, 2018, v. 78, n. 12, p. 896, doi. 10.1002/pros.23646
- By:
- Publication type:
- Article
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
- Published in:
- Prostate, 2016, v. 76, n. 6, p. 597, doi. 10.1002/pros.23151
- By:
- Publication type:
- Article
Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 8, p. 709, doi. 10.1002/pros.24684
- By:
- Publication type:
- Article
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 1009, doi. 10.1007/s10549-011-1894-3
- By:
- Publication type:
- Article
Inferring cancer subnetwork markers using density-constrained biclustering.
- Published in:
- Bioinformatics, 2010, v. 26, n. 18, p. i625, doi. 10.1093/bioinformatics/btq393
- By:
- Publication type:
- Article
Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
- Published in:
- Cancer Reports, 2019, v. 2, n. 2, p. N.PAG, doi. 10.1002/cnr2.1153
- By:
- Publication type:
- Article
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27024-x
- By:
- Publication type:
- Article
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21245-w
- By:
- Publication type:
- Article
Diagnostic and Prognostic Sarcoma Signatures.
- Published in:
- Molecular Diagnosis & Therapy, 2008, v. 12, n. 6, p. 359, doi. 10.1007/BF03256302
- By:
- Publication type:
- Article
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2169, doi. 10.1002/cncr.34790
- By:
- Publication type:
- Article
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
- Published in:
- Journal of Pathology, 2019, v. 249, n. 4, p. 411, doi. 10.1002/path.5315
- By:
- Publication type:
- Article
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 2, p. 1, doi. 10.1002/2056-4538.12363
- By:
- Publication type:
- Article
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
- Published in:
- Nature Communications, 2014, v. 5, n. 11, p. 5383, doi. 10.1038/ncomms6383
- By:
- Publication type:
- Article
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066855
- By:
- Publication type:
- Article
Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis.
- Published in:
- Research & Reports in Urology, 2016, v. 8, p. 77, doi. 10.2147/RRU.S99997
- By:
- Publication type:
- Article
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
- Published in:
- Nature Genetics, 2013, v. 45, n. 11, p. 1392, doi. 10.1038/ng.2771
- By:
- Publication type:
- Article
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02140-y
- By:
- Publication type:
- Article
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1656, doi. 10.1093/jnci/djac162
- By:
- Publication type:
- Article
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju290
- By:
- Publication type:
- Article
Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 6437, doi. 10.1002/cam4.5399
- By:
- Publication type:
- Article
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.
- Published in:
- BJU International, 2017, v. 119, n. 6, p. 961, doi. 10.1111/bju.13779
- By:
- Publication type:
- Article
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 556, doi. 10.1111/bju.13013
- By:
- Publication type:
- Article
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery.
- Published in:
- BJU International, 2015, v. 115, n. 3, p. 419, doi. 10.1111/bju.12789
- By:
- Publication type:
- Article
Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3994, doi. 10.1002/1878-0261.13314
- By:
- Publication type:
- Article
Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer.
- Published in:
- Biology of the Cell (Wiley-Blackwell), 2015, v. 107, n. 7, p. 232, doi. 10.1111/boc.201400097
- By:
- Publication type:
- Article
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2223, doi. 10.1007/s00432-021-03634-2
- By:
- Publication type:
- Article
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 883, doi. 10.1007/s00432-018-2615-7
- By:
- Publication type:
- Article
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85151-3
- By:
- Publication type:
- Article